Clinical Trials Directory

Trials / Conditions / Castration-Sensitive Prostate Carcinoma

Castration-Sensitive Prostate Carcinoma

8 registered clinical trials studyying Castration-Sensitive Prostate Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for
NCT06931340
Alliance for Clinical Trials in OncologyPhase 3
RecruitingFDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostat
NCT06244004
Northwestern UniversityPhase 2
TerminatedVudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Se
NCT05733351
Emory UniversityPhase 1
Active Not RecruitingTesting Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Pr
NCT05241860
Alliance for Clinical Trials in OncologyPhase 2
RecruitingTalazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prosta
NCT04734730
City of Hope Medical CenterPhase 2
TerminatedAntiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treatin
NCT03649841
University of WashingtonPhase 2
Active Not RecruitingAdvanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
NCT04267887
OHSU Knight Cancer InstitutePhase 2
TerminatedDocetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Canc
NCT03827473
University of UtahPhase 2